Litcius/Paper detail

Asciminib: First Approval

Emma D. Deeks

2022Drugs63 citationsDOI

Topics & Concepts

MedicineTyrosine kinaseDrug developmentPharmacologyChronic myeloid leukaemiaPharmacotherapyDrugDrug approvalTyrosine-kinase inhibitorDrug resistanceNilotinibIntensive care medicineOff-label useAllosteric regulationClinical pharmacologyOrally activeInternal medicineClinical trialPhases of clinical researchCombination therapyTargeted therapyDrug holidayChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and Treatment